Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Daniel Stadlbauer and Florian Krammer.
Daniel Stadlbauer
Connection Strength
3.785
Florian Krammer
  1. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 2021 02; 590(7844):146-150.
    View in: PubMed
    Score: 0.911
  2. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 2020 06; 57(1):e100.
    View in: PubMed
    Score: 0.885
  3. Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses? Front Med. 2017 Dec; 11(4):471-479.
    View in: PubMed
    Score: 0.743
  4. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 04 08; 384(14):1372-1374.
    View in: PubMed
    Score: 0.233
  5. Anti-SARS-CoV-2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks. Transfusion. 2020 10; 60(10):2457-2459.
    View in: PubMed
    Score: 0.226
  6. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 07; 26(7):1033-1036.
    View in: PubMed
    Score: 0.220
  7. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers. J Infect Dis. 2021 07 02; 224(1):70-80.
    View in: PubMed
    Score: 0.060
  8. Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun. 2021 06 18; 12(1):3781.
    View in: PubMed
    Score: 0.059
  9. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. 2021 07; 9(7):712-720.
    View in: PubMed
    Score: 0.059
  10. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021 Jul; 2(7):e283-e284.
    View in: PubMed
    Score: 0.059
  11. SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020. MMWR Morb Mortal Wkly Rep. 2021 03 05; 70(9):308-311.
    View in: PubMed
    Score: 0.058
  12. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 12 04; 370(6521):1227-1230.
    View in: PubMed
    Score: 0.057
  13. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020 11; 26(11):1708-1713.
    View in: PubMed
    Score: 0.056
  14. Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults. Clin Infect Dis. 2020 05 23; 70(11):2290-2297.
    View in: PubMed
    Score: 0.055
  15. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat Med. 2019 06; 25(6):962-967.
    View in: PubMed
    Score: 0.052
  16. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Front Immunol. 2019; 10:756.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.